Stocktoria

Neuronetics, Inc. STIM

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-06-28 · LEI

Neuronetics, Inc. financials (annual)

Revenue
$40.4M $52.8M $62.7M $49.2M $55.3M $65.2M $71.3M $74.9M $149.2M 201720182019202020212022202320242025
Net income
-$16.1M -$24.1M -$29.0M -$27.5M -$31.2M -$37.2M -$30.2M -$43.7M -$39.0M 201720182019202020212022202320242025
Free cash flow
201720182019202020212022202320242025

Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$149.2M$74.9M$71.3M$65.2M$55.3M$49.2M$62.7M$52.8M$40.4M
Gross profit$72.3M$54.2M$51.7M$49.7M$43.7M$37.7M$47.3M$40.3M$30.8M
R&D expense$6.6M$12.8M$9.5M$9.3M$7.9M$9.2M$13.7M$8.2M$7.9M
Operating income-$31.4M-$34.6M-$30.6M-$35.1M-$27.6M-$22.3M-$26.9M-$19.8M-$13.6M
Interest expense$7.3M$5.4M$4.3M$4.0M$4.5M$3.7M$3.7M$2.8M
Net income-$39.0M-$43.7M-$30.2M-$37.2M-$31.2M-$27.5M-$29.0M-$24.1M-$16.1M
EPS (diluted)$-0.59$-1.38$-1.05$-1.38$-1.22$-1.46$-1.58
Operating cash flow-$20.4M-$31.0M-$32.0M-$30.7M-$28.0M-$28.4M-$30.5M-$20.6M-$11.1M
Cash & equivalents$28.1M$18.5M$59.7M$70.3M$94.1M$49.0M$75.7M$104.6M$29.1M
Inventory$4.3M$4.2M$8.1M$8.9M$6.6M$3.7M$2.8M$2.4M$2.5M
Total assets$141.6M$140.9M$115.8M$116.9M$141.2M$78.7M$100.2M$117.0M$38.9M
Total liabilities$115.3M$109.1M$81.6M$59.8M$56.0M$53.2M$52.3M$46.0M$44.5M
Shareholders' equity$26.2M$31.8M$34.2M$57.1M$85.2M$25.5M$47.9M$71.0M-$192.7M

Growth · year-over-year · Revenue CAGR 17.7%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth+99.2%+5.0%+9.4%+17.9%+12.3%-21.4%+18.7%+30.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.